APOE genotype is a major predictor of long-term progression of disability in MS
- PMID: 11171894
- DOI: 10.1212/wnl.56.3.312
APOE genotype is a major predictor of long-term progression of disability in MS
Abstract
Background and objective: The authors recently reported that the APOE epsilon4 allele is associated with significantly greater progression of disability in a 2-year follow-up of patients with MS. In this study, these findings are substantiated and extended in a much larger group of patients followed for up to 40 years.
Methods: Two hundred five patients with clinically definite MS who were genotyped for the APOE epsilon4 carrier state were included. Groups of patients with (n = 41) and without (n = 164) APOE epsilon4 alleles were compared for latency to expanded disability status scale (EDSS) scores of 4.0 and 6.0 by Kaplan-Meier analysis with the log rank test. The results were adjusted for age at onset and sex by Cox regression analysis.
Results: The APOE epsilon4 allele frequency in patients with MS (0.10) was similar to that in the general Israeli population. There was a significant effect of APOE genotype on the latency to reach EDSS 4.0 and 6.0 (p = 0.0002 and p = 0.0006 by two-tailed log rank test). Median latencies were shorter by 12 and 11 years in the APOE epsilon4 group for these outcomes. These results were significant after adjustment for age at onset and sex.
Conclusions: The APOE epsilon4 allele is associated with significantly faster progression of disability in MS. This is the first genetic factor to be identified with a major impact on the progression of disability in this disease.
Comment in
-
APOE genotype is a major predictor of long-term progression of disability in MS.Neurology. 2001 Dec 11;57(11):2148-9. doi: 10.1212/wnl.57.11.2148. Neurology. 2001. PMID: 11739852 No abstract available.
Similar articles
-
Preliminary observations on APOE epsilon4 allele and progression of disability in multiple sclerosis.Arch Neurol. 1999 Dec;56(12):1484-7. doi: 10.1001/archneur.56.12.1484. Arch Neurol. 1999. PMID: 10593303
-
Apo E in multiple sclerosis and optic neuritis: the apo E-epsilon4 allele is associated with progression of multiple sclerosis.Mult Scler. 2005 Oct;11(5):511-5. doi: 10.1191/1352458505ms1207oa. Mult Scler. 2005. PMID: 16193886
-
Association of apolipoprotein E genotypes with prognosis in multiple sclerosis.Eur Rev Med Pharmacol Sci. 2011 Oct;15(10):1122-30. Eur Rev Med Pharmacol Sci. 2011. PMID: 22165672
-
The association between apolipoprotein E and multiple sclerosis.Eur J Neurol. 2006 Jun;13(6):573-80. doi: 10.1111/j.1468-1331.2006.01360.x. Eur J Neurol. 2006. PMID: 16796581 Review.
-
The effects of APOE genotype on age at onset and progression of neurodegenerative diseases.Neurology. 2001 Oct 23;57(8):1482-5. doi: 10.1212/wnl.57.8.1482. Neurology. 2001. PMID: 11673593 Review.
Cited by
-
The APOE4 genotype alters the response of microglia and macrophages to 17beta-estradiol.Neurobiol Aging. 2008 Dec;29(12):1783-94. doi: 10.1016/j.neurobiolaging.2007.04.018. Epub 2007 Jun 5. Neurobiol Aging. 2008. PMID: 17553597 Free PMC article.
-
The immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis.Clin Dev Immunol. 2010;2010:186813. doi: 10.1155/2010/186813. Epub 2010 May 31. Clin Dev Immunol. 2010. PMID: 20613949 Free PMC article. Review.
-
ApoE4: an emerging therapeutic target for Alzheimer's disease.BMC Med. 2019 Mar 20;17(1):64. doi: 10.1186/s12916-019-1299-4. BMC Med. 2019. PMID: 30890171 Free PMC article. Review.
-
Apolipoprotein E plays a key role against cryptosporidial infection in transgenic undernourished mice.PLoS One. 2014 Feb 28;9(2):e89562. doi: 10.1371/journal.pone.0089562. eCollection 2014. PLoS One. 2014. PMID: 24586873 Free PMC article.
-
Role of Apolipoproteins and α-Synuclein in Parkinson's Disease.J Mol Neurosci. 2017 Aug;62(3-4):344-355. doi: 10.1007/s12031-017-0942-9. Epub 2017 Jul 10. J Mol Neurosci. 2017. PMID: 28695482 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous